UroActive®
Stress Urinary Incontinence (SUI)
Key Facts
About UroMems
UroMems is a private, clinical-stage medical device company developing the UroActive® implant, a breakthrough automated treatment for stress urinary incontinence. The company leverages a proprietary MyoElectroMechanical Systems (MEMS) technology platform to create smart, active implants that can be adjusted remotely to meet individual patient needs. With over €90 million raised from notable European investors and a robust intellectual property portfolio, UroMems is positioned to address a significant unmet clinical need in a large and growing global market. The company is led by an experienced team of founders and industry veterans with deep expertise in urology, biomedical engineering, and medical device commercialization.
View full company profileTherapeutic Areas
Other Stress Urinary Incontinence (SUI) Drugs
| Drug | Company | Phase |
|---|---|---|
| Durasphere® Injectable Bulking Agent | Carbon Medical Technologies | Commercial |